PharmAthene Articles
PharmAthene gets exclusive rights to Percivia's PER.C6 cell line for recombinant bioscavenger
14 January 2013
PharmAthene awarded 50% profit split on SIGA smallpox drug
25 September 2011
US Government Accountability Office rules PharmAthene can keep $78 million SparVax contract
10 June 2010
Showing 1-4 of 4 articles
- 1
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
